AbbVie Inc (ABBV)

Gross profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Gross profit (ttm)	US$ in thousands	17,466,000	19,820,000	21,466,000	20,410,000	22,372,000	21,987,000	23,240,000	24,311,000	23,753,000	22,361,000	20,298,000	17,813,000	18,388,000	15,912,000	19,565,000	24,214,000	25,827,000	25,412,000	25,254,000	25,162,000
Revenue (ttm)	US$ in thousands	54,318,000	55,138,000	56,023,000	56,741,000	58,054,000	57,819,000	57,349,000	56,725,000	56,197,000	55,169,000	53,729,000	50,195,000	45,804,000	40,650,000	36,227,000	34,057,000	33,266,000	32,867,000	32,624,000	32,647,000
Gross profit margin		32.16%	35.95%	38.32%	35.97%	38.54%	38.03%	40.52%	42.86%	42.27%	40.53%	37.78%	35.49%	40.14%	39.14%	54.01%	71.10%	77.64%	77.32%	77.41%	77.07%

December 31, 2023 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $17,466,000K ÷ $54,318,000K
= 32.16%

AbbVie Inc's gross profit margin has exhibited fluctuations over the past eight quarters, ranging from a high of 70.48% in Q2 2022 to a low of 62.42% in Q4 2023. The trend indicates some variability in the company's ability to generate profits from its core operations over this period. Overall, there seems to have been a slight decline in the gross profit margin in the recent quarters compared to the earlier quarters. This may suggest challenges in managing production costs or pricing strategies that could impact AbbVie's profitability. Further analysis would be required to identify the specific factors driving these changes and their implications for the company's financial performance.